These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 5122052)

  • 1. [Clinical studies in progressive muscular dystrophy].
    Prot J
    Neurol Neurochir Pol; 1971; 5(4):473-8. PubMed ID: 5122052
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical studies in progressive muscular dystrophy.
    Prot J
    Pol Med J; 1972; 11(4):1004-12. PubMed ID: 5078704
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 4. [Muscular dystrophy and its problems].
    Ueda K; Ito T; Nakata T; Ohara T; Matsumoto K
    Nihon Rinsho; 1968 Sep; 26(9):2184-98. PubMed ID: 5752294
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A; Sluga E; Moser K
    Wien Klin Wochenschr; 1971 Feb; 83(7):109-13. PubMed ID: 5547427
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood enzymes in Duchene's progressive muscular dystrophy and their correlation with the clinical and histological pictures.
    Niebrój-Dobosz I; Jedrzejowska H; Hetnarska L
    Acta Med Pol; 1970; 11(4):387-93. PubMed ID: 5493781
    [No Abstract]   [Full Text] [Related]  

  • 7. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
    Esaki K; Tokoro T; Yamamoto K; Kato T; Asano B
    Iryo; 1969 Oct; 23(10):1306-11. PubMed ID: 5364982
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigation on healthy individuals from families of patients with Duchenne type muscular dystrophy.
    Hausmanowa-Petrusewicz I; Prot J; Niebrój-Dobosz I; Emeryk B; Wasowicz B; Slucka C; Hetnarska L; Bendarzewska B; Pucek Z
    Pol Med J; 1968; 7(1):228-37. PubMed ID: 5652928
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum enzyme activities in progressive muscular dystrophy].
    Yano I; Furukawa Y; Masaki H; Tani J
    Nihon Rinsho; 1966 Mar; 24(3):571-5. PubMed ID: 6007312
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contribution on the study of pseudohypertrophic muscular dystrophies. II. Pseudohypertrophic muscular dystrophies in females].
    Radu H; Stenzel K
    Dtsch Z Nervenheilkd; 1969; 196(2):116-35. PubMed ID: 5800953
    [No Abstract]   [Full Text] [Related]  

  • 11. [On Becker's benign muscular dystrophy: study of a family with 10 affected members in 6 generations].
    Caruso G; Campanella G
    Acta Neurol (Napoli); 1968; 23(4):709-31. PubMed ID: 5747395
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinico-biochemical and genetic studies of myopathy].
    Davidenkova EF; Droznina TA; Markelov IM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(11):1623-8. PubMed ID: 6001049
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical features and classification of the muscular dystrophies.
    Gardner-Medwin D
    Br Med Bull; 1980 May; 36(2):109-15. PubMed ID: 7020835
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N; Haţegan D
    Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
    [No Abstract]   [Full Text] [Related]  

  • 15. Benign sex-linked muscular dystrophy. Clinical and pathological features.
    Markand ON; North RR; D'Agostino AN; Daly DD
    Neurology; 1969 Jul; 19(7):617-33. PubMed ID: 5815127
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of serum pyruvate kinase in patients with Duchenne's muscular dystrophy and carriers. Comparison with other enzyme determinations].
    Calandi C; Adami Lami C; Guidotti T; Nistri R; Papuzza S; Tozzi P; Poggi G
    Minerva Pediatr; 1981 May; 33(10):453-64. PubMed ID: 7254147
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modern laboratory methods for diagnosis and prevention of progressive dystrophy].
    Mariani E; Bianchini A
    Riv Neurol; 1968; 38(5):465-8. PubMed ID: 5699645
    [No Abstract]   [Full Text] [Related]  

  • 18. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection.
    Tangorra A; Curatola G; Milani-Comparetti M; Ferretti G
    Am J Med Genet; 1989 Apr; 32(4):540-4. PubMed ID: 2774000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 20. Juvenile motor neuron diseases--the sex influence in benign juvenile pseudodystrophic spinal muscular atrophy.
    Hausmanowa-Petrusewicz I; Borkowska J; Zaremba J
    Adv Neurol; 1982; 36():131-7. PubMed ID: 7180679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.